Pseudomonas fluorescens Strain CL145A; Exemption From the Requirement of a Tolerance, 52871-52875 [2011-21249]
Download as PDF
Federal Register / Vol. 76, No. 164 / Wednesday, August 24, 2011 / Rules and Regulations
*
*
*
*
holidays. The Docket Facility telephone
number is (703) 305–5805.
FOR FURTHER INFORMATION CONTACT: Ann
Sibold, Biopesticides and Pollution
Prevention Division (7511P), Office of
Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460–
0001; telephone number: (703) 305–
6502; e-mail address:
sibold.ann@epa.gov.
*
[FR Doc. 2011–21362 Filed 8–23–11; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2009–0087; FRL–8884–6]
Pseudomonas fluorescens Strain
CL145A; Exemption From the
Requirement of a Tolerance
SUPPLEMENTARY INFORMATION:
I. General Information
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes an
exemption from the requirement of a
tolerance for residues of Pseudomonas
fluorescens strain CL145A in or on all
food commodities when applied as a
molluscicide. Marrone Bio Innovations,
Inc. (formerly Marrone Organic
Innovations, Inc.) submitted a petition
to EPA under the Federal Food, Drug,
and Cosmetic Act (FFDCA) requesting
an exemption from the requirement of a
tolerance. This regulation eliminates the
need to establish a maximum
permissible level for residues of
Pseudomonas fluorescens strain
CL145A under the FFDCA.
DATES: This regulation is effective
August 24, 2011. Objections and
requests for hearings must be received
on or before October 24, 2011, and must
be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
ADDRESSES: EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2009–0087. All documents in the
docket are listed in the docket index
available at https://www.regulations.gov.
Although listed in the index, some
information is not publicly available,
e.g., Confidential Business Information
(CBI) or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
available in hard copy, at the Office of
Pesticide Programs (OPP) Regulatory
Public Docket in Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. The Docket
Facility is open from 8:30 a.m. to 4 p.m.,
Monday through Friday, excluding legal
wreier-aviles on DSKGBLS3C1PROD with RULES
SUMMARY:
VerDate Mar<15>2010
15:25 Aug 23, 2011
Jkt 223001
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, pesticide
manufacturer, hydroelectric power
facility operator or water supply system
operator. Potentially affected entities
may include, but are not limited to:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
• Hydroelectric power generation
(NAICS code 221111).
• Water supply and irrigation systems
(NAICS code 221310).
This listing is not intended to be
exhaustive, but rather provides a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of 40 CFR part 180
through the Government Printing
Office’s e-CFR site at https://
ecfr.gpoaccess.gov/cgi/t/text/textidx?&c=ecfr&tpl=/ecfrbrowse/Title40/
40tab_02.tpl. To access the harmonized
test guidelines referenced in this
document electronically, please go to
https://www.epa.gov/ocspp and select
‘‘Test Methods and Guidelines.’’
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g),
21 U.S.C. 346a(g), any person may file
an objection to any aspect of this
PO 00000
Frm 00021
Fmt 4700
Sfmt 4700
52871
regulation and may also request a
hearing on those objections. You must
file your objection or request a hearing
on this regulation in accordance with
the instructions provided in 40 CFR part
178. To ensure proper receipt by EPA,
you must identify docket ID number
EPA–HQ–OPP–2009–0087 in the subject
line on the first page of your
submission. All objections and requests
for a hearing must be in writing, and
must be received by the Hearing Clerk
on or before October 24, 2011.
Addresses for mail and hand delivery of
objections and hearing requests are
provided in 40 CFR 178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing that does not
contain any CBI for inclusion in the
public docket. Information not marked
confidential pursuant to 40 CFR part 2
may be disclosed publicly by EPA
without prior notice. Submit a copy of
your non-CBI objection or hearing
request, identified by docket ID number
EPA–HQ–OPP–2009–0087, by one of
the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: OPP Regulatory Public Docket
(7502P), Environmental Protection
Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. Deliveries
are only accepted during the Docket
Facility’s normal hours of operation
(8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays).
Special arrangements should be made
for deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
II. Background and Statutory Findings
In the Federal Register of March 16,
2009 (74 FR 11100) (FRL–8405–1), EPA
issued a notice pursuant to section
408(d)(3) of FFDCA, 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide tolerance petition (PP 9F7511)
by Marrone Bio Innovations, Inc.
(formerly Marrone Organic Innovations,
Inc.), 2121 Second Street, Suite B–107,
Davis, CA 95618. The petition requested
that 40 CFR part 180 be amended by
establishing an exemption from the
requirement of a tolerance for residues
of Pseudomonas fluorescens strain
CL145A in or on all food commodities
when applied as a molluscicide. This
notice referenced a summary of the
petition prepared by the petitioner,
E:\FR\FM\24AUR1.SGM
24AUR1
52872
Federal Register / Vol. 76, No. 164 / Wednesday, August 24, 2011 / Rules and Regulations
Marrone Bio Innovations, Inc. (formerly
Marrone Organic Innovations, Inc.),
which is available in the docket via
https://www.regulations.gov. One
comment was received on the notice of
filing. EPA’s response to this comment
is discussed in Unit VII.C.
Section 408(c)(2)(A)(i) of FFDCA
allows EPA to establish an exemption
from the requirement for a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the exemption is ‘‘safe.’’
Section 408(c)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings but does not include
occupational exposure. Pursuant to
section 408(c)(2)(B) of FFDCA, in
establishing or maintaining in effect an
exemption from the requirement of a
tolerance, EPA must take into account
the factors set forth in section
408(b)(2)(C) of FFDCA, which require
EPA to give special consideration to
exposure of infants and children to the
pesticide chemical residue in
establishing a tolerance exemption and
to ‘‘ensure that there is a reasonable
certainty that no harm will result to
infants and children from aggregate
exposure to the pesticide chemical
residue. * * *’’ Additionally, section
408(b)(2)(D) of FFDCA requires that the
EPA consider ‘‘available information
concerning the cumulative effects of [a
particular pesticide’s] * * * residues
and other substances that have a
common mechanism of toxicity.’’
EPA performs a number of analyses to
determine the risks from aggregate
exposure to pesticide residues. First,
EPA determines the toxicity of
pesticides. Second, EPA examines
exposure to the pesticide through food,
drinking water, and through other
exposures that occur as a result of
pesticide use in residential settings.
wreier-aviles on DSKGBLS3C1PROD with RULES
III. Toxicological Profile
Consistent with section 408(b)(2)(D)
of FFDCA, EPA has reviewed the
available scientific data and other
relevant information in support of this
action and considered its validity,
completeness, and reliability and the
relationship of this information to
human risk. EPA has also considered
available information concerning the
variability of the sensitivities of major
identifiable subgroups of consumers,
including infants and children.
VerDate Mar<15>2010
15:25 Aug 23, 2011
Jkt 223001
A. Overview of Pseudomonas
fluorescens and Pseudomonas
fluorescens Strain CL145A
Pseudomonas fluorescens is
ubiquitous in soil and water and is
commonly associated with plants,
including those food plants consumed
raw. The Manual of Clinical
Microbiology (8th edition) states the
following: ‘‘Pseudomonas spp. have a
worldwide distribution with a
predilection for moist environments.
They are found in water and soil and on
plants, including fruits and vegetables’’
(Ref. 1). Although Pseudomonas
fluorescens is of low virulence and
usually not clinically significant, it has
been associated with opportunistic
infections in compromised patients
when Pseudomonas fluorescenscontaminated blood product was used
for transfusions.
In the past, EPA has registered several
pesticide products, each containing a
different isolate of Pseudomonas
fluorescens as an active ingredient:
1. Pseudomonas fluorescens strain
NCIB 12089—used as a mushroom
blotch control agent and exempted from
the requirement of a tolerance (40 CFR
180.1129) in the Federal Register of
August 24, 1994 (59 FR 43490) (FRL–
4899–5);
2. Pseudomonas fluorescens A506
and Pseudomonas fluorescens 1629RS—
used for reduction of frost and frost
damage on various food crops and
exempted from the requirement of a
tolerance (40 CFR 180.1114) in the
Federal Register of September 16, 1992
(57 FR 42700) (FRL–4161–1); and
3. Pseudomonas fluorescens EG–
1053—used for control of the PythiumRhizoctonia seedling disease complex of
cotton and exempted from the
requirement of a tolerance (40 CFR
180.1088) in the Federal Register of
March 10, 1988 (53 FR 7740) (FRL–
3339–2).
Out of these isolates, only
Pseudomonas fluorescens A506 is still
contained in an actively registered
pesticide product.
Pseudomonas fluorescens strain
CL145A is a naturally occurring
bacterial species that was isolated from
a river mud sample in the northeastern
United States. This isolate is being
registered as a biocontrol agent for zebra
mussels (Dreissena polymorpha) and
quagga mussels (Dreissena bugensis)
that infest enclosed and other confined
static or flowing water infrastructures
(e.g., water storage chambers and tanks,
pipes, general plumbing and equipment,
and other water conveyance structures
associated with civil infrastructure).
When a zebra or quagga mussel ingests
PO 00000
Frm 00022
Fmt 4700
Sfmt 4700
artificially high densities of
Pseudomonas fluorescens strain
CL145A, a toxin within this bacterium’s
cells destroys the digestive system of the
mussel.
B. Microbial Pesticide Toxicology Data
Requirements
All mammalian toxicology data
requirements supporting the request for
an exemption from the requirement of a
tolerance for residues of Pseudomonas
fluorescens strain CL145A in or on all
food commodities have been fulfilled
with data submitted by the petitioner or
data waiver requests that have been
granted by EPA. Acceptable (i.e., data
that are scientifically sound and useful
for risk assessment) acute oral toxicity,
acute inhalation toxicity, and acute
pulmonary toxicity/pathogenicity data,
which addressed potential routes of
exposure to the active ingredient and
which tested doses significantly higher
than or comparable to the labeled
application rates, were classified in
Toxicity Categories IV or III (toxicity
studies) (see 40 CFR 156.62) or
indicated that Pseudomonas fluorescens
CL145A was not toxic, infective and/or
pathogenic (toxicity/pathogenicity
study). The overall conclusions from all
toxicological information submitted by
the petitioner is described below, while
more in-depth synopses of the study
results can be found in the associated
Biopesticides Registration Action
Document provided as a reference in
Unit IX. (Ref. 2).
1. Acute oral toxicity—rat
(Harmonized Guideline 870.1100;
Master Record Identification Number
(MRID No.) 476402–02). An acceptable
acute oral toxicity study demonstrated
that Pseudomonas fluorescens strain
CL145A was not toxic to rats when
dosed at 5,000 milligrams per kilogram
(mg/kg) (or 2.35 × 1010 colony-forming
units per kilogram (CFU/kg)). The no
observed adverse effect level (NOAEL)
and median lethal dose (LD50) (i.e., a
statistically derived single dose that can
be expected to cause death in 50% of
test animals) were greater than 5,000
mg/kg (or greater than 2.35 × 1010 CFU/
kg) (Toxicity Category IV).
2. Acute oral toxicity/pathogenicity
(Harmonized Guideline 885.3050; MRID
No). 477494–03). The rationale provided
in support of a data waiver request for
acute oral toxicity/pathogenicity stated
that Pseudomonas fluorescens is
considered an ubiquitous inhabitant of
soil and water and is found on the
surface and roots of a variety of plant
types, including food plants consumed
raw. Pseudomonads and, in particular,
Pseudomonas fluorescens are
considered a benign part of the regular
E:\FR\FM\24AUR1.SGM
24AUR1
wreier-aviles on DSKGBLS3C1PROD with RULES
Federal Register / Vol. 76, No. 164 / Wednesday, August 24, 2011 / Rules and Regulations
human diet commonly occurring on the
surface of leafy green vegetables and
other food stuffs (Refs. 1, 3, and 4).
Additionally, an acute oral toxicity
study conducted on rats (MRID No.
476402–02) found the NOAEL and LD50
were greater than 5,000 mg/kg,
corresponding to greater than 2.35 ×
1010 CFU/kg (Toxicity Category IV).
Based on this rationale, oral infectivity,
clearance, and pathogenicity testing for
Pseudomonas fluorescens strain
CL145A was waived. It should be noted
that this is a different data requirement
from the acute oral toxicity test
(Harmonized Guideline 870.1100; MRID
No. 476402–02), which only evaluated
toxicity, but not pathogenicity and
infectivity potential, of the microbial
pest control agent.
3. Acute inhalation toxicity—rat
(Harmonized Guideline 870.1300; MRID
No. 476402–04). An acceptable acute
inhalation toxicity study demonstrated
that Pseudomonas fluorescens strain
CL145A was not toxic to rats when
exposed to approximately 0.225
milligrams per liter (mg/L) (or 1.1 × 106
colony-forming units per liter (CFU/L)).
The NOAEL and median lethal
concentration (LC50) were greater than
0.225 mg/L (or greater than 1.1 × 106
CFU/L) (Toxicity Category II but
upgraded to Toxicity Category III with
the results of MRID No. 482767–02. The
dose used in the acute pulmonary
toxicity/pathogenicity study (MRID No.
482767–02), which looked at the same
route of exposure and did not show any
toxicity, pathogenicity, and/or
infectivity, was greater than the dose
used in the study described in this unit.
Thus, this allowed the Toxicity
Category, as initially established in this
study, to be upgraded from II to III.).
4. Acute pulmonary toxicity/
pathogenicity—rat (Harmonized
Guideline 885.3150; MRID No. 482767–
02). An acceptable acute pulmonary
toxicity and pathogenicity study
demonstrated that Pseudomonas
fluorescens strain CL145A was not
toxic, infective, and/or pathogenic to
rats when dosed intratrachaelly at 3.4 ×
108 colony-forming units (CFU)/rat. As
detailed in the acute inhalation toxicity
study summary in this unit, this study
upgraded the Toxicity Category for
MRID No. 476402–04 from II to III.
5. Acute dermal toxicity—rat
(Harmonized Guideline 870.1200; MRID
No. 476402–03). An acceptable acute
dermal toxicity study demonstrated that
Pseudomonas fluorescens strain
CL145A was not toxic to rats when
dosed at 5,050 mg/kg (or 2.38 × 1010
CFU/kg). The LD50 was greater than
5,050 mg/kg (or greater than 2.38 × 1010
CFU/kg) (Toxicity Category IV).
VerDate Mar<15>2010
15:25 Aug 23, 2011
Jkt 223001
6. Acute eye irritation—rabbit
(Harmonized Guideline 870.2400; MRID
No. 476402–05). An acceptable acute
eye irritation study demonstrated that
Pseudomonas fluorescens strain
CL145A was practically non-irritating to
rabbits (irritation symptoms cleared by
48 hours; Toxicity Category IV).
7. Primary dermal irritation—rabbit
(Harmonized Guideline 870.2500; MRID
No. 476402–06). An acceptable primary
dermal irritation study demonstrated
that Pseudomonas fluorescens strain
CL145A was practically non-irritating to
rabbits (irritation symptoms cleared by
24 hours; Toxicity Category IV).
IV. Aggregate Exposure
In examining aggregate exposure,
section 408 of FFDCA directs EPA to
consider available information
concerning exposures from the pesticide
residue in food and all other nonoccupational exposures, including
drinking water from ground water or
surface water and exposure through
pesticide use in gardens, lawns, or
buildings (residential and other indoor
uses).
A. Dietary Exposure
Pseudomonas fluorescens strain
CL145A end-use products are not
labeled for direct application to food
crops. Any potential food exposures
would be as a result of its presence in
water. Thus, minimal dietary exposure
to this microbial pesticide may occur
through irrigation water, wash water or
drinking water (see discussions of food
and drinking water exposures in this
unit); however, the lack of acute oral
toxicity, as exhibited in a toxicology test
on rats, and the rationales justifying the
waiver of acute oral toxicity/
pathogenicity testing (see Unit III.B.)
support the establishment of a tolerance
exemption for residues of Pseudomonas
fluorescens strain CL145A.
1. Food. Exposure to this microbial
active ingredient through food is
expected to be minimal. Pseudomonas
fluorescens strain CL145A end-use
products are not labeled for direct
application to food crops. Rather,
Pseudomonas fluorescens strain
CL145A will be applied to water in
enclosed and other confined static or
flowing water infrastructures to control
zebra and quagga mussels. The
treatment areas are limited to
completely enclosed pipe or water
conveyance systems or concrete
chambers with defined inlets or outlets.
Nevertheless, water drawn downstream
from points of application (e.g., pump
stations and irrigation systems) and
used to irrigate or wash food crops may
contain Pseudomonas fluorescens strain
PO 00000
Frm 00023
Fmt 4700
Sfmt 4700
52873
CL145A. Concentrations of
Pseudomonas fluorescens will be
diluted as water flows past points of
application and thus will rapidly
decrease. Also, natural degradation (e.g.,
environmental factors such as
ultraviolet light, nutrient depletion and
bacterial grazing/predation by protists
and others) and manmade filtering
operations are expected to greatly lower
the overall level of the pesticide after
application (Refs. 5 and 6). Furthermore,
Pseudomonas fluorescens is considered
ubiquitous in soil and water and is
commonly associated with plants,
including food plants consumed raw;
thus, this microorganism is already part
of the normal human diet (Refs. 1, 3,
and 4). Exposure to Pseudomonas
fluorescens strain CL145A through food
that has come into contact with treated
irrigation or wash waters is not expected
to exceed background levels of similar
Pseudomonads already present in the
human diet (Refs. 1, 3, and 4).
Nonetheless, in the unlikely event that
this microbial pesticide is present on
food, the acute oral toxicity and
pathogenicity data/information
demonstrated no toxicity, infectivity
and/or pathogenicity is likely to occur
with any exposure level of
Pseudomonas fluorescens strain
CL145A (see additional discussion in
Unit III.B.).
2. Drinking water exposure. Much like
food exposure, drinking water exposure
is expected to be negligible for similar
reasons:
i. Concentrations of Pseudomonas
fluorescens strain CL145A will be
diluted as water flows past points of
application;
ii. Natural degradation (e.g.,
environmental factors such as
ultraviolet light, nutrient depletion and
bacterial grazing/predation by protists
and others) of the microbial active
ingredient will occur; and
iii. Flocculation and filtering at water
treatment plants will further inactivate
and decrease levels of Pseudomonas
fluorescens strain CL145A (Refs. 5 and
6). Additionally, Pseudomonas
fluorescens is already present naturally
in soil, in water, and on plants, thereby
making it a part of the normal human
diet (Refs. 1, 3, and 4). Exposure to
Pseudomonas fluorescens strain
CL145A through drinking water is not
expected to exceed background levels of
similar Pseudomonads already present
in the human diet (Refs. 1, 3, and 4).
Nonetheless, in the unlikely event that
this microbial pesticide is present in
drinking water, the acute oral toxicity
and pathogenicity data/information
demonstrated no toxicity, infectivity
and/or pathogenicity is likely to occur
E:\FR\FM\24AUR1.SGM
24AUR1
52874
Federal Register / Vol. 76, No. 164 / Wednesday, August 24, 2011 / Rules and Regulations
with any exposure level of
Pseudomonas fluorescens strain
CL145A (see additional discussion in
Unit III.B.).
wreier-aviles on DSKGBLS3C1PROD with RULES
B. Other Non-Occupational Exposure
Dermal and inhalation nonoccupational exposure to Pseudomonas
fluorescens strain CL145A is expected
to be minimal to non-existent.
Pseudomonas fluorescens strain
CL145A end-use products are labeled
for application to use sites—enclosed
and other confined static or flowing
water infrastructures infested with zebra
and/or quagga mussels—that are not
considered residential areas.
1. Dermal exposure. Although dermal
exposure to Pseudomonas fluorescens
strain CL145A may occur when water
from a treated dam or industrial facility
is discharged to surface water and is
subsequently used by a community
water system in a residential area, such
exposure is expected to be minimal due
to dilution, natural degradation, and
filtering at water treatment plants (Refs.
5 and 6). Moreover, acute dermal
toxicity and primary dermal irritation
tests demonstrated that Pseudomonas
fluorescens strain CL145A is not toxic
and is practically non-irritating via the
dermal route of exposure (see additional
discussion in Unit III.B.).
2. Inhalation exposure. Inhalation
exposure to Pseudomonas fluorescens
strain CL145A is not anticipated with
the labeled (i.e., water-based)
molluscicide use. If inhalation exposure
to Pseudomonas fluorescens strain
CL145A were to occur in gardens,
lawns, or buildings (i.e., residential
areas), such exposure would not exceed
EPA’s level of concern given the acute
inhalation toxicity and acute pulmonary
toxicity/pathogenicity tests that
demonstrated Pseudomonas fluorescens
strain CL145A’s lack of toxicity,
pathogenicity and/or infectivity (see
additional discussion in Unit III.B.).
V. Cumulative Effects From Substances
With a Common Mechanism of Toxicity
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance exemption, EPA consider
‘‘available information concerning the
cumulative effects of [a particular
pesticide’s] * * * residues and other
substances that have a common
mechanism of toxicity.’’
EPA has not found Pseudomonas
fluorescens strain CL145A to share a
common mechanism of toxicity with
any other substances. Pseudomonas
fluorescens strain CL145A affects gut
function in the target molluscs and does
not produce a similar toxic response in
VerDate Mar<15>2010
15:25 Aug 23, 2011
Jkt 223001
the other species tested. For the
purposes of this tolerance action,
therefore, EPA has assumed that
Pseudomonas fluorescens strain
CL145A does not have a common
mechanism of toxicity with other
substances. Following from this,
therefore, EPA concludes that there are
no cumulative effects associated with
Pseudomonas fluorescens strain
CL145A that need to be considered. For
information regarding EPA’s efforts to
determine which chemicals have a
common mechanism of toxicity and to
evaluate the cumulative effects of such
chemicals, see EPA’s website at https://
www.epa.gov/pesticides/cumulative.
VI. Determination of Safety for U.S.
Population, Infants and Children
FFDCA section 408(b)(2)(C) provides
that EPA shall assess the available
information about consumption patterns
among infants and children, special
susceptibility of infants and children to
pesticide chemical residues, and the
cumulative effects on infants and
children of the residues and other
substances with a common mechanism
of toxicity. In addition, FFDCA section
408(b)(2)(C) provides that EPA shall
apply an additional tenfold (10X)
margin of safety for infants and children
in the case of threshold effects to
account for prenatal and postnatal
toxicity and the completeness of the
database on toxicity and exposure
unless EPA determines that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
Food Quality Protection Act Safety
Factor. In applying this provision, EPA
either retains the default value of 10X or
uses a different additional safety factor
when reliable data available to EPA
support the choice of a different factor.
Based on the acute toxicity and
pathogenicity data/information
discussed in Unit III.B., EPA concludes
that there is a reasonable certainty that
no harm will result to the U.S.
population, including infants and
children, from aggregate exposure to the
residues of Pseudomonas fluorescens
strain CL145A. Such exposure includes
all anticipated dietary exposures and all
other exposures for which there is
reliable information. EPA has arrived at
this conclusion because, considered
collectively, the data (e.g., lack of
toxicity noted for oral, dermal, and
inhalation routes of exposure) available
on Pseudomonas fluorescens strain
CL145A do not demonstrate toxic,
pathogenic, and/or infective potential to
sensitive populations from exposure to
this microbial pest control agent. Thus,
there are no threshold effects of concern
PO 00000
Frm 00024
Fmt 4700
Sfmt 4700
and, as a result, an additional margin of
safety is not necessary.
VII. Other Considerations
A. Analytical Enforcement Methodology
An analytical method is not required
for enforcement purposes since EPA is
establishing an exemption from the
requirement of a tolerance without any
numerical limitation.
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. In this context, EPA considers
the international maximum residue
limits (MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint U.N.
Food and Agriculture Organization/
World Health Organization food
standards program, and it is recognized
as an international food safety
standards-setting organization in trade
agreements to which the United States
is a party. EPA may establish a tolerance
that is different from a Codex MRL;
however, FFDCA section 408(b)(4)
requires that EPA explain the reasons
for departing from the Codex level.
The Codex has not established a MRL
for Pseudomonas fluorescens strain
CL145A.
C. Response to Comments
In response to the Notice of Filing,
EPA received one comment, protesting
the presence of this product in food, the
proposed exemption from the
requirement of a tolerance, and the
toxicity of the product. In response, EPA
again emphasizes that Pseudomonas
fluorescens strain CL145A is present
naturally in soil and water (Refs. 1, 3,
and 4), is not toxic, pathogenic, and/or
infective for dietary considerations (see
additional discussion in Unit III.B.),
and, in any event, is expected to
degrade quickly in the environment
(Ref. 6). Biological materials from dead
cells would be consumed by degradative
microflora in treatment areas, and the
few live cells diluted in treated waters
would likely not approach the levels of
Pseudomonas fluorescens already
present in water, in soil, and on foods
(Refs. 1, 3, 4, and 6). EPA has concluded
there is a reasonable certainty that no
harm will result to the U.S. population,
including infants and children, from
aggregate exposure to residues of
Pseudomonas fluorescens strain
CL145A in or on all food commodities
(see Unit VIII.). Thus, under the
E:\FR\FM\24AUR1.SGM
24AUR1
Federal Register / Vol. 76, No. 164 / Wednesday, August 24, 2011 / Rules and Regulations
standard in FFDCA section 408(c)(2), a
tolerance exemption is appropriate.
VIII. Conclusions
EPA concludes that there is a
reasonable certainty that no harm will
result to the U.S. population, including
infants and children, from aggregate
exposure to residues of Pseudomonas
fluorescens strain CL145A. Therefore,
an exemption from the requirement of a
tolerance is established for residues of
Pseudomonas fluorescens strain
CL145A in or on all food commodities
when applied as a molluscicide.
IX. References
wreier-aviles on DSKGBLS3C1PROD with RULES
1. Murray PR, Baron E, Jorgensen JH, Pfaller
MA, Yolken RH, editors. 2003. Manual of
Clinical Biology. 8th ed. Washington
(DC): ASM Press.
2. U.S. EPA. 2011. Pseudomonas fluorescens
strain CL145A Biopesticides Registration
Action Document dated July 2011
(available as ‘‘Supporting & Related
Material’’ within docket ID number
EPA–HQ–OPP–2011–0568 at https://
www.regulations.gov).
3. Garrity GM, Bell JA, Lilburn T, editors.
2005. ‘‘Pseudomonadales’’ in Bergey’s
Manual of Systematic Bacteriology. 2nd
ed. New York (NY): Springer.
4. Organisation for Economic Co-operation
and Development. 1997. Consensus
Document on Information Used in the
Assessment of Environmental
Applications Involving Pseudomonas.
Available from https://www.rebecanet.de/downloads/
OECD%20Consensus%20document%
20pseudomonas.pdf.
5. U.S. EPA. 2004. Primer for Municipal
Wastewater Treatment Systems. EPA
832–R–04–001.
6. U.S. EPA. 1996. Microbial Pesticide Test
Guidelines—Background for Residue
Analysis of Microbial Pest Control
Agents (OPPTS 885.2000). Available
from https://www.epa.gov/ocspp/pubs/
frs/publications/Test_Guidelines/
series885.htm.
X. Statutory and Executive Order
Reviews
This final rule establishes a tolerance
exemption under section 408(d) of
FFDCA in response to a petition
submitted to EPA. The Office of
Management and Budget (OMB) has
exempted these types of actions from
review under Executive Order 12866,
entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993).
Because this final rule has been
exempted from review under Executive
Order 12866, this final rule is not
subject to Executive Order 13211,
entitled Actions Concerning Regulations
That Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May
22, 2001), or Executive Order 13045,
entitled Protection of Children from
VerDate Mar<15>2010
15:25 Aug 23, 2011
Jkt 223001
Environmental Health Risks and Safety
Risks (62 FR 19885, April 23, 1997).
This final rule does not contain any
information collections subject to OMB
approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et
seq., nor does it require any special
considerations under Executive Order
12898, entitled Federal Actions to
Address Environmental Justice in
Minority Populations and Low-Income
Populations (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under section 408(d) of FFDCA, such as
the tolerance exemption in this final
rule, do not require the issuance of a
proposed rule, the requirements of the
Regulatory Flexibility Act (RFA) (5
U.S.C. 601 et seq.) do not apply.
This final rule directly regulates
growers, food processors, food handlers,
and food retailers, not States or tribes.
As a result, this action does not alter the
relationships or distribution of power
and responsibilities established by
Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such,
EPA has determined that this action will
not have a substantial direct effect on
States or tribal governments, on the
relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, EPA has determined that
Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999), and Executive Order 13175,
entitled Consultation and Coordination
with Indian Tribal Governments (65 FR
67249, November 9, 2000), do not apply
to this final rule. In addition, this final
rule does not impose any enforceable
duty or contain any unfunded mandate
as described under Title II of the
Unfunded Mandates Reform Act of 1995
(UMRA) (Pub. L. 104–4).
This action does not involve any
technical standards that would require
EPA consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act of 1995
(NTTAA), Public Law 104–113, section
12(d) (15 U.S.C. 272 note).
XI. Congressional Review Act
The Congressional Review Act, 5
U.S.C. 801 et seq., generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report to each House of
the Congress and to the Comptroller
General of the United States. EPA will
submit a report containing this rule and
PO 00000
Frm 00025
Fmt 4700
Sfmt 4700
52875
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of this final rule in the
Federal Register. This final rule is not
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: July 29, 2011.
Steven Bradbury,
Director, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. Section 180.1304 is added to
subpart D to read as follows:
■
§ 180.1304 Pseudomonas fluorescens
strain CL145A; exemption from the
requirement of a tolerance.
An exemption from the requirement
of a tolerance is established for residues
of Pseudomonas fluorescens strain
CL145A in or on all food commodities
when applied as a molluscicide.
[FR Doc. 2011–21249 Filed 8–23–11; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2011–0430; FRL–8881–5]
2-Propenoic Acid, Polymer With
Ethenylbenzene and (1-methylethenyl)
Benzene, Sodium Salt; Tolerance
Exemption
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes an
exemption from the requirement of a
tolerance for residues of 2-Propenoic
acid, polymer with ethenylbenzene and
(1-methylethenyl) benzene, sodium salt
when used as an inert ingredient in a
pesticide chemical formulation under
40 CFR 180.960. BASF Corporation
submitted a petition to EPA under the
Federal Food, Drug, and Cosmetic Act
(FFDCA), requesting an exemption from
the requirement of a tolerance. This
SUMMARY:
E:\FR\FM\24AUR1.SGM
24AUR1
Agencies
[Federal Register Volume 76, Number 164 (Wednesday, August 24, 2011)]
[Rules and Regulations]
[Pages 52871-52875]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21249]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2009-0087; FRL-8884-6]
Pseudomonas fluorescens Strain CL145A; Exemption From the
Requirement of a Tolerance
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes an exemption from the requirement
of a tolerance for residues of Pseudomonas fluorescens strain CL145A in
or on all food commodities when applied as a molluscicide. Marrone Bio
Innovations, Inc. (formerly Marrone Organic Innovations, Inc.)
submitted a petition to EPA under the Federal Food, Drug, and Cosmetic
Act (FFDCA) requesting an exemption from the requirement of a
tolerance. This regulation eliminates the need to establish a maximum
permissible level for residues of Pseudomonas fluorescens strain CL145A
under the FFDCA.
DATES: This regulation is effective August 24, 2011. Objections and
requests for hearings must be received on or before October 24, 2011,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2009-0087. All documents in the
docket are listed in the docket index available at https://www.regulations.gov. Although listed in the index, some information is
not publicly available, e.g., Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute. Certain
other material, such as copyrighted material, is not placed on the
Internet and will be publicly available only in hard copy form.
Publicly available docket materials are available in the electronic
docket at https://www.regulations.gov, or, if only available in hard
copy, at the Office of Pesticide Programs (OPP) Regulatory Public
Docket in Rm. S-4400, One Potomac Yard (South Bldg.), 2777 S. Crystal
Dr., Arlington, VA. The Docket Facility is open from 8:30 a.m. to 4
p.m., Monday through Friday, excluding legal holidays. The Docket
Facility telephone number is (703) 305-5805.
FOR FURTHER INFORMATION CONTACT: Ann Sibold, Biopesticides and
Pollution Prevention Division (7511P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001; telephone number: (703) 305-6502; e-mail
address: sibold.ann@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, pesticide manufacturer,
hydroelectric power facility operator or water supply system operator.
Potentially affected entities may include, but are not limited to:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
Hydroelectric power generation (NAICS code 221111).
Water supply and irrigation systems (NAICS code 221310).
This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of 40 CFR
part 180 through the Government Printing Office's e-CFR site at https://ecfr.gpoaccess.gov/cgi/t/text/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl. To access the harmonized test guidelines referenced in
this document electronically, please go to https://www.epa.gov/ocspp and
select ``Test Methods and Guidelines.''
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a(g), any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2009-0087 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing, and must be received by the Hearing Clerk on or before
October 24, 2011. Addresses for mail and hand delivery of objections
and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing that does not contain any CBI for inclusion in the public
docket. Information not marked confidential pursuant to 40 CFR part 2
may be disclosed publicly by EPA without prior notice. Submit a copy of
your non-CBI objection or hearing request, identified by docket ID
number EPA-HQ-OPP-2009-0087, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: OPP Regulatory Public Docket (7502P), Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is (703) 305-5805.
II. Background and Statutory Findings
In the Federal Register of March 16, 2009 (74 FR 11100) (FRL-8405-
1), EPA issued a notice pursuant to section 408(d)(3) of FFDCA, 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide tolerance
petition (PP 9F7511) by Marrone Bio Innovations, Inc. (formerly Marrone
Organic Innovations, Inc.), 2121 Second Street, Suite B-107, Davis, CA
95618. The petition requested that 40 CFR part 180 be amended by
establishing an exemption from the requirement of a tolerance for
residues of Pseudomonas fluorescens strain CL145A in or on all food
commodities when applied as a molluscicide. This notice referenced a
summary of the petition prepared by the petitioner,
[[Page 52872]]
Marrone Bio Innovations, Inc. (formerly Marrone Organic Innovations,
Inc.), which is available in the docket via https://www.regulations.gov.
One comment was received on the notice of filing. EPA's response to
this comment is discussed in Unit VII.C.
Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an
exemption from the requirement for a tolerance (the legal limit for a
pesticide chemical residue in or on a food) only if EPA determines that
the exemption is ``safe.'' Section 408(c)(2)(A)(ii) of FFDCA defines
``safe'' to mean that ``there is a reasonable certainty that no harm
will result from aggregate exposure to the pesticide chemical residue,
including all anticipated dietary exposures and all other exposures for
which there is reliable information.'' This includes exposure through
drinking water and in residential settings but does not include
occupational exposure. Pursuant to section 408(c)(2)(B) of FFDCA, in
establishing or maintaining in effect an exemption from the requirement
of a tolerance, EPA must take into account the factors set forth in
section 408(b)(2)(C) of FFDCA, which require EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance exemption and to ``ensure
that there is a reasonable certainty that no harm will result to
infants and children from aggregate exposure to the pesticide chemical
residue. * * *'' Additionally, section 408(b)(2)(D) of FFDCA requires
that the EPA consider ``available information concerning the cumulative
effects of [a particular pesticide's] * * * residues and other
substances that have a common mechanism of toxicity.''
EPA performs a number of analyses to determine the risks from
aggregate exposure to pesticide residues. First, EPA determines the
toxicity of pesticides. Second, EPA examines exposure to the pesticide
through food, drinking water, and through other exposures that occur as
a result of pesticide use in residential settings.
III. Toxicological Profile
Consistent with section 408(b)(2)(D) of FFDCA, EPA has reviewed the
available scientific data and other relevant information in support of
this action and considered its validity, completeness, and reliability
and the relationship of this information to human risk. EPA has also
considered available information concerning the variability of the
sensitivities of major identifiable subgroups of consumers, including
infants and children.
A. Overview of Pseudomonas fluorescens and Pseudomonas fluorescens
Strain CL145A
Pseudomonas fluorescens is ubiquitous in soil and water and is
commonly associated with plants, including those food plants consumed
raw. The Manual of Clinical Microbiology (8th edition) states the
following: ``Pseudomonas spp. have a worldwide distribution with a
predilection for moist environments. They are found in water and soil
and on plants, including fruits and vegetables'' (Ref. 1). Although
Pseudomonas fluorescens is of low virulence and usually not clinically
significant, it has been associated with opportunistic infections in
compromised patients when Pseudomonas fluorescens-contaminated blood
product was used for transfusions.
In the past, EPA has registered several pesticide products, each
containing a different isolate of Pseudomonas fluorescens as an active
ingredient:
1. Pseudomonas fluorescens strain NCIB 12089--used as a mushroom
blotch control agent and exempted from the requirement of a tolerance
(40 CFR 180.1129) in the Federal Register of August 24, 1994 (59 FR
43490) (FRL-4899-5);
2. Pseudomonas fluorescens A506 and Pseudomonas fluorescens
1629RS--used for reduction of frost and frost damage on various food
crops and exempted from the requirement of a tolerance (40 CFR
180.1114) in the Federal Register of September 16, 1992 (57 FR 42700)
(FRL-4161-1); and
3. Pseudomonas fluorescens EG-1053--used for control of the
Pythium-Rhizoctonia seedling disease complex of cotton and exempted
from the requirement of a tolerance (40 CFR 180.1088) in the Federal
Register of March 10, 1988 (53 FR 7740) (FRL-3339-2).
Out of these isolates, only Pseudomonas fluorescens A506 is still
contained in an actively registered pesticide product.
Pseudomonas fluorescens strain CL145A is a naturally occurring
bacterial species that was isolated from a river mud sample in the
northeastern United States. This isolate is being registered as a
biocontrol agent for zebra mussels (Dreissena polymorpha) and quagga
mussels (Dreissena bugensis) that infest enclosed and other confined
static or flowing water infrastructures (e.g., water storage chambers
and tanks, pipes, general plumbing and equipment, and other water
conveyance structures associated with civil infrastructure). When a
zebra or quagga mussel ingests artificially high densities of
Pseudomonas fluorescens strain CL145A, a toxin within this bacterium's
cells destroys the digestive system of the mussel.
B. Microbial Pesticide Toxicology Data Requirements
All mammalian toxicology data requirements supporting the request
for an exemption from the requirement of a tolerance for residues of
Pseudomonas fluorescens strain CL145A in or on all food commodities
have been fulfilled with data submitted by the petitioner or data
waiver requests that have been granted by EPA. Acceptable (i.e., data
that are scientifically sound and useful for risk assessment) acute
oral toxicity, acute inhalation toxicity, and acute pulmonary toxicity/
pathogenicity data, which addressed potential routes of exposure to the
active ingredient and which tested doses significantly higher than or
comparable to the labeled application rates, were classified in
Toxicity Categories IV or III (toxicity studies) (see 40 CFR 156.62) or
indicated that Pseudomonas fluorescens CL145A was not toxic, infective
and/or pathogenic (toxicity/pathogenicity study). The overall
conclusions from all toxicological information submitted by the
petitioner is described below, while more in-depth synopses of the
study results can be found in the associated Biopesticides Registration
Action Document provided as a reference in Unit IX. (Ref. 2).
1. Acute oral toxicity--rat (Harmonized Guideline 870.1100; Master
Record Identification Number (MRID No.) 476402-02). An acceptable acute
oral toxicity study demonstrated that Pseudomonas fluorescens strain
CL145A was not toxic to rats when dosed at 5,000 milligrams per
kilogram (mg/kg) (or 2.35 x 10\10\ colony-forming units per kilogram
(CFU/kg)). The no observed adverse effect level (NOAEL) and median
lethal dose (LD50) (i.e., a statistically derived single
dose that can be expected to cause death in 50% of test animals) were
greater than 5,000 mg/kg (or greater than 2.35 x 10\10\ CFU/kg)
(Toxicity Category IV).
2. Acute oral toxicity/pathogenicity (Harmonized Guideline
885.3050; MRID No). 477494-03). The rationale provided in support of a
data waiver request for acute oral toxicity/pathogenicity stated that
Pseudomonas fluorescens is considered an ubiquitous inhabitant of soil
and water and is found on the surface and roots of a variety of plant
types, including food plants consumed raw. Pseudomonads and, in
particular, Pseudomonas fluorescens are considered a benign part of the
regular
[[Page 52873]]
human diet commonly occurring on the surface of leafy green vegetables
and other food stuffs (Refs. 1, 3, and 4). Additionally, an acute oral
toxicity study conducted on rats (MRID No. 476402-02) found the NOAEL
and LD50 were greater than 5,000 mg/kg, corresponding to
greater than 2.35 x 1010 CFU/kg (Toxicity Category IV).
Based on this rationale, oral infectivity, clearance, and pathogenicity
testing for Pseudomonas fluorescens strain CL145A was waived. It should
be noted that this is a different data requirement from the acute oral
toxicity test (Harmonized Guideline 870.1100; MRID No. 476402-02),
which only evaluated toxicity, but not pathogenicity and infectivity
potential, of the microbial pest control agent.
3. Acute inhalation toxicity--rat (Harmonized Guideline 870.1300;
MRID No. 476402-04). An acceptable acute inhalation toxicity study
demonstrated that Pseudomonas fluorescens strain CL145A was not toxic
to rats when exposed to approximately 0.225 milligrams per liter (mg/L)
(or 1.1 x 106 colony-forming units per liter (CFU/L)). The
NOAEL and median lethal concentration (LC50) were greater
than 0.225 mg/L (or greater than 1.1 x 106 CFU/L) (Toxicity
Category II but upgraded to Toxicity Category III with the results of
MRID No. 482767-02. The dose used in the acute pulmonary toxicity/
pathogenicity study (MRID No. 482767-02), which looked at the same
route of exposure and did not show any toxicity, pathogenicity, and/or
infectivity, was greater than the dose used in the study described in
this unit. Thus, this allowed the Toxicity Category, as initially
established in this study, to be upgraded from II to III.).
4. Acute pulmonary toxicity/pathogenicity--rat (Harmonized
Guideline 885.3150; MRID No. 482767-02). An acceptable acute pulmonary
toxicity and pathogenicity study demonstrated that Pseudomonas
fluorescens strain CL145A was not toxic, infective, and/or pathogenic
to rats when dosed intratrachaelly at 3.4 x 108 colony-
forming units (CFU)/rat. As detailed in the acute inhalation toxicity
study summary in this unit, this study upgraded the Toxicity Category
for MRID No. 476402-04 from II to III.
5. Acute dermal toxicity--rat (Harmonized Guideline 870.1200; MRID
No. 476402-03). An acceptable acute dermal toxicity study demonstrated
that Pseudomonas fluorescens strain CL145A was not toxic to rats when
dosed at 5,050 mg/kg (or 2.38 x 1010 CFU/kg). The
LD50 was greater than 5,050 mg/kg (or greater than 2.38 x
1010 CFU/kg) (Toxicity Category IV).
6. Acute eye irritation--rabbit (Harmonized Guideline 870.2400;
MRID No. 476402-05). An acceptable acute eye irritation study
demonstrated that Pseudomonas fluorescens strain CL145A was practically
non-irritating to rabbits (irritation symptoms cleared by 48 hours;
Toxicity Category IV).
7. Primary dermal irritation--rabbit (Harmonized Guideline
870.2500; MRID No. 476402-06). An acceptable primary dermal irritation
study demonstrated that Pseudomonas fluorescens strain CL145A was
practically non-irritating to rabbits (irritation symptoms cleared by
24 hours; Toxicity Category IV).
IV. Aggregate Exposure
In examining aggregate exposure, section 408 of FFDCA directs EPA
to consider available information concerning exposures from the
pesticide residue in food and all other non-occupational exposures,
including drinking water from ground water or surface water and
exposure through pesticide use in gardens, lawns, or buildings
(residential and other indoor uses).
A. Dietary Exposure
Pseudomonas fluorescens strain CL145A end-use products are not
labeled for direct application to food crops. Any potential food
exposures would be as a result of its presence in water. Thus, minimal
dietary exposure to this microbial pesticide may occur through
irrigation water, wash water or drinking water (see discussions of food
and drinking water exposures in this unit); however, the lack of acute
oral toxicity, as exhibited in a toxicology test on rats, and the
rationales justifying the waiver of acute oral toxicity/pathogenicity
testing (see Unit III.B.) support the establishment of a tolerance
exemption for residues of Pseudomonas fluorescens strain CL145A.
1. Food. Exposure to this microbial active ingredient through food
is expected to be minimal. Pseudomonas fluorescens strain CL145A end-
use products are not labeled for direct application to food crops.
Rather, Pseudomonas fluorescens strain CL145A will be applied to water
in enclosed and other confined static or flowing water infrastructures
to control zebra and quagga mussels. The treatment areas are limited to
completely enclosed pipe or water conveyance systems or concrete
chambers with defined inlets or outlets. Nevertheless, water drawn
downstream from points of application (e.g., pump stations and
irrigation systems) and used to irrigate or wash food crops may contain
Pseudomonas fluorescens strain CL145A. Concentrations of Pseudomonas
fluorescens will be diluted as water flows past points of application
and thus will rapidly decrease. Also, natural degradation (e.g.,
environmental factors such as ultraviolet light, nutrient depletion and
bacterial grazing/predation by protists and others) and manmade
filtering operations are expected to greatly lower the overall level of
the pesticide after application (Refs. 5 and 6). Furthermore,
Pseudomonas fluorescens is considered ubiquitous in soil and water and
is commonly associated with plants, including food plants consumed raw;
thus, this microorganism is already part of the normal human diet
(Refs. 1, 3, and 4). Exposure to Pseudomonas fluorescens strain CL145A
through food that has come into contact with treated irrigation or wash
waters is not expected to exceed background levels of similar
Pseudomonads already present in the human diet (Refs. 1, 3, and 4).
Nonetheless, in the unlikely event that this microbial pesticide is
present on food, the acute oral toxicity and pathogenicity data/
information demonstrated no toxicity, infectivity and/or pathogenicity
is likely to occur with any exposure level of Pseudomonas fluorescens
strain CL145A (see additional discussion in Unit III.B.).
2. Drinking water exposure. Much like food exposure, drinking water
exposure is expected to be negligible for similar reasons:
i. Concentrations of Pseudomonas fluorescens strain CL145A will be
diluted as water flows past points of application;
ii. Natural degradation (e.g., environmental factors such as
ultraviolet light, nutrient depletion and bacterial grazing/predation
by protists and others) of the microbial active ingredient will occur;
and
iii. Flocculation and filtering at water treatment plants will
further inactivate and decrease levels of Pseudomonas fluorescens
strain CL145A (Refs. 5 and 6). Additionally, Pseudomonas fluorescens is
already present naturally in soil, in water, and on plants, thereby
making it a part of the normal human diet (Refs. 1, 3, and 4). Exposure
to Pseudomonas fluorescens strain CL145A through drinking water is not
expected to exceed background levels of similar Pseudomonads already
present in the human diet (Refs. 1, 3, and 4). Nonetheless, in the
unlikely event that this microbial pesticide is present in drinking
water, the acute oral toxicity and pathogenicity data/information
demonstrated no toxicity, infectivity and/or pathogenicity is likely to
occur
[[Page 52874]]
with any exposure level of Pseudomonas fluorescens strain CL145A (see
additional discussion in Unit III.B.).
B. Other Non-Occupational Exposure
Dermal and inhalation non-occupational exposure to Pseudomonas
fluorescens strain CL145A is expected to be minimal to non-existent.
Pseudomonas fluorescens strain CL145A end-use products are labeled for
application to use sites--enclosed and other confined static or flowing
water infrastructures infested with zebra and/or quagga mussels--that
are not considered residential areas.
1. Dermal exposure. Although dermal exposure to Pseudomonas
fluorescens strain CL145A may occur when water from a treated dam or
industrial facility is discharged to surface water and is subsequently
used by a community water system in a residential area, such exposure
is expected to be minimal due to dilution, natural degradation, and
filtering at water treatment plants (Refs. 5 and 6). Moreover, acute
dermal toxicity and primary dermal irritation tests demonstrated that
Pseudomonas fluorescens strain CL145A is not toxic and is practically
non-irritating via the dermal route of exposure (see additional
discussion in Unit III.B.).
2. Inhalation exposure. Inhalation exposure to Pseudomonas
fluorescens strain CL145A is not anticipated with the labeled (i.e.,
water-based) molluscicide use. If inhalation exposure to Pseudomonas
fluorescens strain CL145A were to occur in gardens, lawns, or buildings
(i.e., residential areas), such exposure would not exceed EPA's level
of concern given the acute inhalation toxicity and acute pulmonary
toxicity/pathogenicity tests that demonstrated Pseudomonas fluorescens
strain CL145A's lack of toxicity, pathogenicity and/or infectivity (see
additional discussion in Unit III.B.).
V. Cumulative Effects From Substances With a Common Mechanism of
Toxicity
Section 408(b)(2)(D)(v) of FFDCA requires that, when considering
whether to establish, modify, or revoke a tolerance exemption, EPA
consider ``available information concerning the cumulative effects of
[a particular pesticide's] * * * residues and other substances that
have a common mechanism of toxicity.''
EPA has not found Pseudomonas fluorescens strain CL145A to share a
common mechanism of toxicity with any other substances. Pseudomonas
fluorescens strain CL145A affects gut function in the target molluscs
and does not produce a similar toxic response in the other species
tested. For the purposes of this tolerance action, therefore, EPA has
assumed that Pseudomonas fluorescens strain CL145A does not have a
common mechanism of toxicity with other substances. Following from
this, therefore, EPA concludes that there are no cumulative effects
associated with Pseudomonas fluorescens strain CL145A that need to be
considered. For information regarding EPA's efforts to determine which
chemicals have a common mechanism of toxicity and to evaluate the
cumulative effects of such chemicals, see EPA's website at https://www.epa.gov/pesticides/cumulative.
VI. Determination of Safety for U.S. Population, Infants and Children
FFDCA section 408(b)(2)(C) provides that EPA shall assess the
available information about consumption patterns among infants and
children, special susceptibility of infants and children to pesticide
chemical residues, and the cumulative effects on infants and children
of the residues and other substances with a common mechanism of
toxicity. In addition, FFDCA section 408(b)(2)(C) provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines that a different margin of safety
will be safe for infants and children. This additional margin of safety
is commonly referred to as the Food Quality Protection Act Safety
Factor. In applying this provision, EPA either retains the default
value of 10X or uses a different additional safety factor when reliable
data available to EPA support the choice of a different factor.
Based on the acute toxicity and pathogenicity data/information
discussed in Unit III.B., EPA concludes that there is a reasonable
certainty that no harm will result to the U.S. population, including
infants and children, from aggregate exposure to the residues of
Pseudomonas fluorescens strain CL145A. Such exposure includes all
anticipated dietary exposures and all other exposures for which there
is reliable information. EPA has arrived at this conclusion because,
considered collectively, the data (e.g., lack of toxicity noted for
oral, dermal, and inhalation routes of exposure) available on
Pseudomonas fluorescens strain CL145A do not demonstrate toxic,
pathogenic, and/or infective potential to sensitive populations from
exposure to this microbial pest control agent. Thus, there are no
threshold effects of concern and, as a result, an additional margin of
safety is not necessary.
VII. Other Considerations
A. Analytical Enforcement Methodology
An analytical method is not required for enforcement purposes since
EPA is establishing an exemption from the requirement of a tolerance
without any numerical limitation.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. In this
context, EPA considers the international maximum residue limits (MRLs)
established by the Codex Alimentarius Commission (Codex), as required
by FFDCA section 408(b)(4). The Codex Alimentarius is a joint U.N. Food
and Agriculture Organization/World Health Organization food standards
program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level.
The Codex has not established a MRL for Pseudomonas fluorescens
strain CL145A.
C. Response to Comments
In response to the Notice of Filing, EPA received one comment,
protesting the presence of this product in food, the proposed exemption
from the requirement of a tolerance, and the toxicity of the product.
In response, EPA again emphasizes that Pseudomonas fluorescens strain
CL145A is present naturally in soil and water (Refs. 1, 3, and 4), is
not toxic, pathogenic, and/or infective for dietary considerations (see
additional discussion in Unit III.B.), and, in any event, is expected
to degrade quickly in the environment (Ref. 6). Biological materials
from dead cells would be consumed by degradative microflora in
treatment areas, and the few live cells diluted in treated waters would
likely not approach the levels of Pseudomonas fluorescens already
present in water, in soil, and on foods (Refs. 1, 3, 4, and 6). EPA has
concluded there is a reasonable certainty that no harm will result to
the U.S. population, including infants and children, from aggregate
exposure to residues of Pseudomonas fluorescens strain CL145A in or on
all food commodities (see Unit VIII.). Thus, under the
[[Page 52875]]
standard in FFDCA section 408(c)(2), a tolerance exemption is
appropriate.
VIII. Conclusions
EPA concludes that there is a reasonable certainty that no harm
will result to the U.S. population, including infants and children,
from aggregate exposure to residues of Pseudomonas fluorescens strain
CL145A. Therefore, an exemption from the requirement of a tolerance is
established for residues of Pseudomonas fluorescens strain CL145A in or
on all food commodities when applied as a molluscicide.
IX. References
1. Murray PR, Baron E, Jorgensen JH, Pfaller MA, Yolken RH, editors.
2003. Manual of Clinical Biology. 8th ed. Washington (DC): ASM
Press.
2. U.S. EPA. 2011. Pseudomonas fluorescens strain CL145A
Biopesticides Registration Action Document dated July 2011
(available as ``Supporting & Related Material'' within docket ID
number EPA-HQ-OPP-2011-0568 at https://www.regulations.gov).
3. Garrity GM, Bell JA, Lilburn T, editors. 2005.
``Pseudomonadales'' in Bergey's Manual of Systematic Bacteriology.
2nd ed. New York (NY): Springer.
4. Organisation for Economic Co-operation and Development. 1997.
Consensus Document on Information Used in the Assessment of
Environmental Applications Involving Pseudomonas. Available from
https://www.rebeca-net.de/downloads/OECD%20Consensus%20document%20pseudomonas.pdf.
5. U.S. EPA. 2004. Primer for Municipal Wastewater Treatment
Systems. EPA 832-R-04-001.
6. U.S. EPA. 1996. Microbial Pesticide Test Guidelines--Background
for Residue Analysis of Microbial Pest Control Agents (OPPTS
885.2000). Available from https://www.epa.gov/ocspp/pubs/frs/publications/Test_Guidelines/series885.htm.
X. Statutory and Executive Order Reviews
This final rule establishes a tolerance exemption under section
408(d) of FFDCA in response to a petition submitted to EPA. The Office
of Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993). Because this final rule has been
exempted from review under Executive Order 12866, this final rule is
not subject to Executive Order 13211, entitled Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use (66 FR 28355, May 22, 2001), or Executive Order 13045, entitled
Protection of Children from Environmental Health Risks and Safety Risks
(62 FR 19885, April 23, 1997). This final rule does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et seq., nor does it require any
special considerations under Executive Order 12898, entitled Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under section 408(d) of FFDCA, such as the tolerance
exemption in this final rule, do not require the issuance of a proposed
rule, the requirements of the Regulatory Flexibility Act (RFA) (5
U.S.C. 601 et seq.) do not apply.
This final rule directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes. As a result, this
action does not alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such, EPA has determined that this
action will not have a substantial direct effect on States or tribal
governments, on the relationship between the national government and
the States or tribal governments, or on the distribution of power and
responsibilities among the various levels of government or between the
Federal Government and Indian tribes. Thus, EPA has determined that
Executive Order 13132, entitled Federalism (64 FR 43255, August 10,
1999), and Executive Order 13175, entitled Consultation and
Coordination with Indian Tribal Governments (65 FR 67249, November 9,
2000), do not apply to this final rule. In addition, this final rule
does not impose any enforceable duty or contain any unfunded mandate as
described under Title II of the Unfunded Mandates Reform Act of 1995
(UMRA) (Pub. L. 104-4).
This action does not involve any technical standards that would
require EPA consideration of voluntary consensus standards pursuant to
section 12(d) of the National Technology Transfer and Advancement Act
of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272
note).
XI. Congressional Review Act
The Congressional Review Act, 5 U.S.C. 801 et seq., generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report to each House of the Congress and to
the Comptroller General of the United States. EPA will submit a report
containing this rule and other required information to the U.S. Senate,
the U.S. House of Representatives, and the Comptroller General of the
United States prior to publication of this final rule in the Federal
Register. This final rule is not a ``major rule'' as defined by 5
U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: July 29, 2011.
Steven Bradbury,
Director, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. Section 180.1304 is added to subpart D to read as follows:
Sec. 180.1304 Pseudomonas fluorescens strain CL145A; exemption from
the requirement of a tolerance.
An exemption from the requirement of a tolerance is established for
residues of Pseudomonas fluorescens strain CL145A in or on all food
commodities when applied as a molluscicide.
[FR Doc. 2011-21249 Filed 8-23-11; 8:45 am]
BILLING CODE 6560-50-P